Effect of vitamin D supplementation on surgical site infection among critically ill adults
Published
May 31, 2025
Paper ID
PAP-000171
Status
Published
DOI
10.65712/tmj.test000429
Advance Services
Abstract
Background: The cost of surgical site infection to health systems is substantial. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.53 (95% CI 0.40 to 0.87). Serious adverse events were rare and similar between groups. Conclusion: Residual confounding cannot be excluded.
Introduction
Guidelines make only a weak recommendation on vitamin D supplementation. surgical site infection remains a leading cause of avoidable harm among critically ill adults.
The cost of surgical site infection to health systems is substantial. Earlier studies of vitamin D supplementation were small or single-centre. surgical site infection remains a leading cause of avoidable harm among critically ill adults.
Earlier studies of vitamin D supplementation were small or single-centre. Guidelines make only a weak recommendation on vitamin D supplementation. surgical site infection remains a leading cause of avoidable harm among critically ill adults.
Materials and Methods
The primary outcome was surgical site infection, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was surgical site infection, assessed blind to allocation. We conducted a pilot feasibility study across 9 centres between 2020 and 2021. Analyses were adjusted for age, sex and baseline severity. Eligible participants were critically ill adults.
Results
Serious adverse events were rare and similar between groups. 3133 participants were included (median age 76 years). 4445 participants were included (median age 59 years).
4618 participants were included (median age 65 years). Effects were consistent across prespecified subgroups. 3431 participants were included (median age 38 years). The adjusted odds ratio was 0.45 (95% CI 0.25 to 0.75).
Serious adverse events were rare and similar between groups. 3531 participants were included (median age 49 years). Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % |
|---|---|---|---|
| Age ≥ 65 | 853 | 33 | 16.5 |
| Centre B | 256 | 61 | 35.8 |
| Male | 619 | 65 | 34.8 |
| Age ≥ 65 | 199 | 16 | 19.7 |
| Age ≥ 65 | 881 | 31 | 37.0 |
Values are n (%) unless stated otherwise.

Shown for critically ill adults; error bars are 95% confidence intervals.
3586 participants were included (median age 36 years). 3899 participants were included (median age 31 years). Effects were consistent across prespecified subgroups.
Discussion
Implementation will depend on staffing, cost and local protocols. These findings suggest that vitamin D supplementation is associated with better surgical site infection in critically ill adults.
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
These findings suggest that vitamin D supplementation is associated with better surgical site infection in critically ill adults. Future work should test vitamin D supplementation in a pragmatic multicentre trial.
Conclusions
Vitamin D supplementation should be considered for critically ill adults to improve surgical site infection.
References
1. Costa X, Haddad O, et al. Home-based cardiac rehabilitation and length of stay. Crit Care Med. 2024;214(9):372-1725.
2. Yilmaz G, Silva E, et al. Nurse-led discharge planning and 30-day readmission. Ann Intern Med. 2025;49(8):201-1510.
3. Nasser P, Zhang C, et al. Pharmacist-led medication review and in-hospital mortality. Pediatrics. 2024;286(4):565-1215.
4. Dubois P, Ibrahim M, et al. Tranexamic acid and 30-day readmission. Lancet. 2017;190(8):23-1366.
5. Lindqvist Z, Osei Q, et al. Continuous glucose monitoring and acute kidney injury. JAMA. 2016;205(3):352-953.
6. Larsen B, Okafor N, et al. High-flow nasal oxygen and time to diagnosis. JAMA. 2011;284(11):508-1373.
Appendices
Ethics approval: IRB-4051.